sternoclavicular joint arthrosis — not mistaking aching at the junction of the sternum and clavicle from throwing, bench press, and heavy lifting for a distal clavicle fracture sequela, thoracic outlet syndrome, or Tietze syndrome: Dr. Moriwaki organizes the boundary between the intra-articular inflammatory environment that peri-sternoclavicular injection of stem cell conditioned media can target, and the bony deformity itself that it cannot reverse, in men aged 40 and above2026.08.07
“My chest at the base has been aching lately.” “The inner clavicle hurts during bench press.” “Every time I circle my arm widely, something catches with a grinding sensation at the junction of the sternum and clavicle.” — Among men aged 40 and above, quite a few actually struggle with such symptoms. The cause is often the overlooked sternoclavicular joint arthrosis — that is, osteoarthritis occurring in the small joint where the manubrium of the sternum meets the medial end of the clavicle. It is diagnosed far less often than knee or hip osteoarthritis, and is frequently mistaken for a sequela of a distal clavicle fracture, thoracic outlet syndrome, or Tietze syndrome. In this article, Dr. Moriwaki organizes the pathology of sternoclavicular joint arthrosis, the diseases to differentiate it from, and the boundary between what peri-sternoclavicular injection of stem cell conditioned media can and cannot target.
Key Points
・Sternoclavicular joint arthrosis is an easily overlooked osteoarthritis that becomes chronic in men aged 40 and above with heavy lifting, throwing motions, and repeated bench pressing, and is frequently misdiagnosed as a distal clavicle fracture sequela, thoracic outlet syndrome, or Tietze syndrome.
・The core pathology is joint space narrowing, articular disc degeneration, and a chronic synovitis cycle between the manubrium of the sternum and the medial end of the clavicle. CT and contrast-enhanced MRI are the cornerstone of diagnosis.
・Peri-sternoclavicular injection of stem cell conditioned media aims to correct the intra-articular inflammatory environment. It does not reverse already-formed osteophytes or joint space narrowing itself.
・The overriding safety principle is to rule out infectious and autoimmune arthritis such as septic sternoclavicular arthritis, SAPHO syndrome, rheumatoid arthritis, and ankylosing spondylitis with blood tests and imaging before proceeding to injection therapy.
・Treatment is a multilayered approach: rest, NSAIDs, and shoulder-girdle exercise therapy as the foundation, combined with peri-articular injection of stem cell conditioned media and, as needed, orthopedic reassessment.
What Is Sternoclavicular Joint Arthrosis — An Easily Overlooked Osteoarthritis
The sternoclavicular joint (SC joint) is a saddle joint where the medial end of the clavicle sits on the upper outer aspect of the manubrium of the sternum, connected by a fibrocartilaginous articular disc — an extremely unique structure. It is the only true joint connecting the upper limb girdle (scapula and clavicle) to the trunk (thorax), and receives sustained shear stress with every motion of raising, rotating, pulling, and pushing the arm. Because the joint space is narrow and the range of motion is small, repeated loading leads to degeneration of cartilage and the articular disc, developing into osteoarthritis.
Who tends to develop this condition?
Sternoclavicular joint arthrosis is common in men aged 40 and above, particularly prominent in those who have long repeated bench press, overhead press, heavy lifting, or throwing motions. Because the joint space is narrow, accumulated repeated shear stress and microtrauma trigger chronic intra-articular inflammation and cartilage degeneration. It can also develop in postmenopausal women from changes in bone metabolism and posture (progression of thoracic kyphosis), and is by no means a rare condition.
Differentiating from commonly mistaken conditions
The pain of sternoclavicular joint arthrosis is often misidentified as follows. A distal clavicle fracture sequela hurts on the lateral end of the clavicle (acromioclavicular joint side), whereas sternoclavicular joint arthrosis hurts at the medial end where it meets the sternum. Thoracic outlet syndrome is accompanied by radiating pain and numbness in the upper arm and forearm, whereas sternoclavicular joint arthrosis is centered on local tenderness with rare neurological symptoms. Tietze syndrome (costosternal syndrome) centers on swelling and tenderness at the costosternal junction of the second to third ribs, located one to two vertebral bodies below the base of the clavicle. Identifying the point of local tenderness and provoking pain by pressing on the medial clavicular end in horizontal adduction is the first differentiation point.
What Is Happening Inside the Joint in Sternoclavicular Joint Arthrosis
Articular disc degeneration and joint space narrowing
Within the sternoclavicular joint sits a circular fibrocartilaginous articular disc, which serves to distribute stress and prevent direct bone-to-bone contact. When chronic shear loading continues, this articular disc degenerates and tears, increasing direct bone-to-bone contact. As a result, the joint space narrows, and osteophytes form on the medial end of the clavicle. On CT imaging, bulging, irregularity, and subchondral cyst formation at the medial end of the clavicle are characteristic. Because reading a plain X-ray is difficult due to the overlap between the clavicle and sternum, CT is the standard for diagnosis.
Chronic synovitis — the “source of pain”
When degenerated cartilage and articular disc fragments are released into the joint, they are recognized as “foreign bodies” by synovial cells, triggering chronic synovitis. From the synovium, inflammatory cytokines and degradative enzymes such as IL-1β, TNF-α, and matrix metalloproteinases (MMPs) are continuously released, which further accelerates degeneration of cartilage, articular disc, and joint capsule. This intra-articular inflammatory cycle is the core mechanism of persistent pain and functional impairment in sternoclavicular joint arthrosis. Bony deformity is a static finding, but the inflammatory loop that keeps turning on its surface is what generates daily pain.
What Peri-Sternoclavicular Injection of Stem Cell Conditioned Media Can and Cannot Target
Peri-articular injection of stem cell conditioned media for sternoclavicular joint arthrosis aims to intervene in this intra-articular inflammatory cycle. Diverse growth factors such as TGF-β, IGF-1, HGF, and VEGF, as well as microRNAs and anti-inflammatory cytokines contained in conditioned media, may suppress inflammatory cytokine production by synovial cells and calm the local inflammatory environment, as suggested at the basic research level. However, there are individual differences and limits, and effectiveness cannot be guaranteed.
What can be targeted: correction of the intra-articular inflammatory environment and improvement of pain scores
What can be clinically expected is improvement in pain scores (VAS) through suppression of chronic synovitis, alleviation of discomfort during motions of rotating, pushing, and raising the arm, and recovery of the quality of activities of daily living. Unlike repeated local injections of steroids, there is less risk of atrophy of surrounding soft tissue, loss of subcutaneous fat, or effects on glucose metabolism — another reason why repeated treatment is easier to consider.
What cannot be targeted: reversal of bony deformity, osteophytes, and joint space narrowing itself
On the other hand, reversing already-formed osteophytes, joint space narrowing, or bony swelling of the medial clavicular end — that is, the structural changes themselves — cannot be expected with peri-articular injection of stem cell conditioned media. In cases dominated by severe bony deformity, joint instability, or recurrent sternoclavicular dislocation, orthopedic arthroplasty or joint resection may be indicated, and orthopedic evaluation should be prioritized first.
Treatment Design and Criteria for Consultation
Treatment for sternoclavicular joint arthrosis is based on activity restriction, short-term NSAIDs, and shoulder-girdle exercise therapy (retraining of the lower trapezius and serratus anterior). If symptoms persist, peri-sternoclavicular injection of stem cell conditioned media is considered. However, when accompanied by fever, rapid swelling, general malaise, worsening night pain, or weight loss, it is necessary to rule out septic sternoclavicular arthritis (rare but serious), SAPHO syndrome, rheumatoid arthritis, ankylosing spondylitis, or sternoclavicular metastasis of malignancy. The safety principle is to reliably rule these out with blood tests (CRP, ESR, RF, anti-CCP antibody, HLA-B27), contrast-enhanced MRI, and if necessary joint aspiration and tissue biopsy, before proceeding to injection therapy.
For information on joint diseases, please also refer to the guidelines of the Japanese Orthopaedic Association. You can also see the treatment details at this page on joint injection of stem cell conditioned media.
Frequently Asked Questions
Q. How is sternoclavicular joint arthrosis diagnosed?
Diagnosis is based on physical findings (localized tenderness at the sternoclavicular joint, provoked pain in horizontal adduction, palpable swelling) and imaging (CT as the standard because plain X-ray is difficult to read due to overlap of clavicle and sternum, with articular disc degeneration evaluated by MRI). When accompanied by fever or acute swelling, be sure to rule out infectious and autoimmune arthritis with blood tests before proceeding to treatment design.
Q. Does peri-sternoclavicular injection of stem cell conditioned media work in a single session?
There are individual differences in effect. Some feel a satisfactory change in one session, while others experience gradual inflammation subsidence over 2–3 doses. Efficacy is objectively evaluated every 2–4 weeks by pain score (VAS), range of motion, and improvement in daily activities. If clear response is lacking, priority goes to orthopedic re-imaging and re-differential diagnosis.
Q. Can I resume sports or training after the injection?
Rest is recommended on the day of injection and the following day. Thereafter, activity is gradually resumed according to the degree of pain. High-load exercises for the sternoclavicular joint — bench press, overhead press, throwing motions — should be avoided for at least two weeks, and it is important to concurrently review form, weight setting, and range of motion to prevent recurrence.
Q. In what cases is surgery considered instead of injection?
Medial claviculectomy or arthroplasty by orthopedics is considered for severe bony deformity with complete loss of joint space, recurrent sternoclavicular dislocation, infectious arthritis, or cases dominated by advanced bone destruction. It is safe to first have an orthopedic surgeon determine whether conservative treatment still has room, and then consider peri-articular injection of stem cell conditioned media in that order.
Q. Are there side effects of joint injection of stem cell conditioned media?
It is regarded as a relatively safe treatment, but temporary pain at the injection site, subcutaneous bruising, and post-injection inflammatory reactions (post-injection flare) can rarely occur. Even with strict sterile technique, the risk of septic arthritis cannot be brought to zero, so please consult immediately if fever, severe pain, rapid swelling, or joint warmth appears after injection.
──────────────
Supervising Physician: Shin Moriwaki, MD
Member of the Japan Society of Aesthetic Surgery (JSAS) / Member of the American Academy of Aesthetic Medicine
ECFMG Certificate
──────────────
📍AVAN TOKYO 銀座 関節再生医療
AVAN TOKYO Ginza Joint Regenerative Medicine
English / 中文 / Tiếng Việt supported
Inquiries via DM / LINE / Website / Phone.